title: Treatment strategies in early and advanced Parkinson disease.
abstract: The initiation of therapy in Parkinson disease (PD), altering the medication, adding new substances, and switching to alternative therapies throughout the disease is always a matter of debate. In the past, experts in PD have propagated different medication strategies. Even though there is no new medical treatment on the horizon, much has changed in consideration of the known treatments in the early and advanced therapy for PD. Therapeutic regimens have to be adapted and adjusted on a regular basis to accomplish the best medical care for the predominant symptom of the individual patient with PD.
authors.affiliation: Division of Neurodegenerative Diseases, Department of Neurology, Dresden University of Technology, Fetscherstraße 74, Dresden 01307, Germany; Department of Neurology, Dresden University of Technology, Fetscherstraße 74, Dresden 01307, Germany; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charité-Universitätsmedizin Berlin, Berlin 10117, Germany. Electronic address: christiana.ossig@charite.de.
authors.forename: Christiana
authors.initials: C
authors.lastname: Ossig
authors.affiliation: Department of Neurology, Dresden University of Technology, Fetscherstraße 74, Dresden 01307, Germany.
authors.forename: Heinz
authors.initials: H
authors.lastname: Reichmann
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D000978:Antiparkinson Agents
keywords: Continuous dopaminergic stimulation; Dopamine agonists; Dyskinesia; Hypokinesia; Levodopa; Parkinson's disease